このエントリーをはてなブックマークに追加
ID 48129
フルテキストURL
Thumnail 124_5.pdf 426 KB
タイトル(別表記)
Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice
著者
朝倉 昇司 国立病院機構岡山医療センター 血液内科
橋本 大吾 岡山大学病院 血液・腫瘍内科
高嶋 秀一郎 九州大学大学院 病態修復内科学
杉山 暖子 岡山大学病院 血液・腫瘍内科
前田 嘉信 岡山大学病院 血液・腫瘍内科
赤司 浩一 九州大学病院 遺伝子細胞療法部
谷本 光音 岡山大学病院 血液・腫瘍内科
豊嶋 崇徳 九州大学病院 遺伝子細胞療法部
キーワード
同種造血幹細胞移植
移植片対白血病効果
programmed death-1 (PD-1)
programmed death ligand-1 (PD-L1)
備考
平成22年度岡山医学会賞(林原賞)受賞論文 (The 2010 Okayama Medical Association Award)
発行日
2012-04-01
出版物タイトル
岡山医学会雑誌
出版物タイトル(別表記)
Journal of Okayama Medical Association
124巻
1号
出版者
岡山医学会
出版者(別表記)
Okayama Medical Association
開始ページ
5
終了ページ
8
ISSN
0030-1558
NCID
AN00032489
資料タイプ
学術雑誌論文
関連URL
http://www.okayama-u.ac.jp/user/oma/
参考文献
1) Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD, Storb R : Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med (1979) 300, 1068-1073.
2) Weiden PL, Flournoy N, Sanders JE, Sullivan KM, Thomas ED : Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation. Transplant Proc (1981) 13, 248-251.
3) Teshima T, Ordemann R, Reddy P, Gagin S, Liu C, Cooke KR, Ferrara JL : Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med (2002) 8, 575-581.
4) Reddy P, Maeda Y, Liu C, Krijanovski OI, Korngold R, Ferrara JL : A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat Med (2005) 11, 1244-1249.
5) Bleakley M, Riddell SR : Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer (2004) 4, 371-380.
6) Asakura S, Hashimoto D, Takashima S, Sugiyama H, Maeda Y, Akashi K, Tanimoto M, Teshima T : Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice. J Clin Invest (2010) 120, 2370-2378.
7) Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, Shlomchik MJ, Emerson SG : Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science (1999) 285, 412-415.
8) Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A : Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (2002) 295, 2097-2100.
9) Jones SC, Murphy GF, Friedman TM, Korngold R : Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model. J Clin Invest (2003) 112, 1880-1886.
10) Korngold R, Sprent J : Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med (1978) 148, 1687-1698.
11) Apperley JF, Jones L, Hale G, Waldmann H, Hows J, Rombos Y, Tsatalas C, Marcus RE, Goolden AW, Gordon-Smith EC, et al. : Bone marrow transplantation for patients with chronic myeloid leukaemia : T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplant (1986) 1, 53-66.
12) Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA, Jacobsen N, Kolb HJ, Rimm AA, Ringden O, et al. : Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood (1990) 75, 2459-2464.
13) Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, Ahmed R : Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med (1998) 188, 2205-2213.
14) Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R : Restoring function in exhausted CD8 T cells during chronic viral infection. Nature (2006) 439, 682-687.
15) Shin H, Wherry EJ : CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol (2007) 19, 408-415.
16) Ahmadzadeh M, Johnson LA, Heemskerk B, Wunderlich JR, Dudley ME, White DE, Rosenberg SA : Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood (2009) 114, 1537-1544.
17) Zhang L, Gajewski TF, Kline J : PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model. Blood (2009) 114, 1545-1552.
18) Mumprecht S, Schurch C, Schwaller J, Solenthaler M,Ochsenbein AF : Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression. Blood (2009) 114, 1528-1536.
19) Blazar BR, Carreno BM, Panoskaltsis-Mortari A, Carter L, Iwai Y, Yagita H, Nishimura H, Taylor PA : Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism. J Immunol (2003) 171, 1272-1277.
言語
Japanese
OAI-PMH Set
岡山大学
著作権者
Copyright (c) 2012 岡山医学会
論文のバージョン
publisher
査読
有り
DOI
Sort Key
2
Eprints Journal Name
joma